What is the prevalence of McCune Albright?

McCune-Albright syndrome (MAS) is an exceptionally rare genetic condition with an estimated prevalence ranging from 1 in 100,000 to 1 in 1,000,000 individuals worldwide. Due to the high clinical variability of the disease, these figures are likely underestimates, as many individuals with milder forms may remain undiagnosed or misdiagnosed throughout their lives.

How common is McCune-Albright syndrome?

McCune-Albright syndrome is classified as an ultra-rare disease. Because it is caused by a post-zygotic somatic mutation in the GNAS gene, it is not inherited from parents, which contributes to its sporadic nature. While exact global counts are difficult to maintain, the rarity of the condition means that many clinicians may only see one or two cases in their entire career. The DiseaseMaps.org community currently includes 62 people with McCune-Albright syndrome, providing a vital real-world perspective on the daily lived experience of this condition, which often exceeds the data found in traditional medical literature.

Does McCune-Albright syndrome affect genders or ethnicities differently?

Current clinical research suggests that McCune-Albright syndrome affects both males and females, though the clinical presentation often differs significantly between sexes. For instance, females are more frequently diagnosed with precocious puberty due to ovarian cysts, which is often one of the earliest clinical signs. There is no evidence of geographic or ethnic predisposition; McCune-Albright syndrome appears to occur with equal frequency across all populations globally. The condition is not inherited, meaning there is no increased risk for siblings of an affected individual.

What are the challenges in identifying the true prevalence?

The primary challenge in determining the accurate prevalence of McCune-Albright syndrome is its wide spectrum of severity. Because the GNAS mutation occurs early in embryonic development, the distribution of affected cells (mosaicism) varies from person to person. This leads to several diagnostic hurdles:

• Mild Presentation: Individuals with limited skeletal involvement or minor skin pigmentation may never seek medical attention.


• Diagnostic Delay: Symptoms like fibrous dysplasia or endocrine overactivity are often treated in isolation by different specialists (orthopedists, endocrinologists, dermatologists) without being recognized as part of McCune-Albright syndrome.


• Lack of Centralized Registries: Because the disease is so rare, there is no single global registry that captures every case, making statistical estimates rely heavily on small-scale clinical studies.

At what age does McCune-Albright syndrome typically appear?

The onset of McCune-Albright syndrome is typically in early childhood, although the age of clinical recognition varies based on the organ systems involved. Cutaneous findings, such as "café-au-lait" spots (often described as having "coast of Maine" borders), are frequently noted in infancy. Endocrine manifestations, particularly early puberty, often lead to a diagnosis in the pediatric years. However, individuals with milder skeletal involvement may not be diagnosed with McCune-Albright syndrome until adolescence or adulthood when bone fractures or deformities occur.

Next steps

• Consult with a pediatric or adult endocrinologist who has specific experience in rare bone and metabolic disorders.


• Connect with the McCune-Albright syndrome community at DiseaseMaps.org to share experiences and learn from others navigating the diagnostic journey.


• Request a referral to a genetic counselor to discuss the somatic nature of the GNAS mutation and to provide education for your family.


• Monitor for multi-system involvement, including regular screenings for endocrine function and skeletal integrity.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: McCune-Albright syndrome (ORPHA:560).


• NIH Genetic and Rare Diseases (GARD) Information Center: McCune-Albright syndrome.


• OMIM (Online Mendelian Inheritance in Man): McCune-Albright Syndrome; MAS.


• National Organization for Rare Disorders (NORD): Rare Disease Database – McCune-Albright Syndrome.